Recently, PuffBar e-cigarettes and similar products have emerged on the market claiming to contain synthetic nicotine – nicotine that is not derived from tobacco, but instead produced in a laboratory. Driving these products are the reduced costs of producing synthetic nicotine and federal policies that incentivize the use of synthetic nicotine, such as the FDA’s temporary restriction on the sale of certain flavored cartridge-based products.
You are here
Persons with mental health or substance use issues or both are more than twice as likely to use tobacco products as the general population. They also are more likely to die as the result of a tobacco-related illness than from their behavioral health conditions. In addition to smoke-free and tobacco-free policies and similar best practices, what tobacco dependency treatment interventions and policies today are effective in helping to reduce tobacco use in the behavioral health setting?